Diferencia entre revisiones de «Ritonavir-boosted nirmatrelvir»
(→COVID) |
|||
| Línea 12: | Línea 12: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===[[COVID]]=== | |||
* 300 mg nirmatrelvir with 100 mg ritonavir, twice daily for 5 days | |||
**Treatment of mild-to-moderate coronavirus disease (COVID-19) pediatric patients (12 years of age and older weighing at least 40 kilograms) that are high risk | |||
**Initiate within 5 days of symptom onset | |||
==Special Populations== | ==Special Populations== | ||
Revisión del 20:22 18 ene 2022
Administration
- Type:
- Dosage Forms:
- Routes of Administration:
- Common Trade Names: Paxlovid
Adult Dosing
COVID
- 300 mg nirmatrelvir with 100 mg ritonavir, twice daily for 5 days
- Treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms) that are high risk
- Initiate within 5 days of symptom onset
Pediatric Dosing
COVID
- 300 mg nirmatrelvir with 100 mg ritonavir, twice daily for 5 days
- Treatment of mild-to-moderate coronavirus disease (COVID-19) pediatric patients (12 years of age and older weighing at least 40 kilograms) that are high risk
- Initiate within 5 days of symptom onset
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
Mechanism of Action
Comments
- renally dosed eGFR 30-60 then 150 mg/100 mg dosing
- 89% reduction in hospitalization or death in high risk population, and 70% reduction in hospitalizations with no deaths in standard risk population.
- Many drug interactions
- E.g. Plavix, Phenytoin, Tacrolimus, Tramadol, Statins, Hydro/oxycodone/Codeine, Diazepam/Clonazepam/Alprazolam, Fentanyl, Tamsulosin